Literature DB >> 12452823

Nasal vaccination induces protective immunity without immunopathology.

T Hussell, I R Humphreys.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12452823      PMCID： PMC1906536          DOI： 10.1046/j.1365-2249.2002.02038.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  27 in total

Review 1.  Chemokines and the tissue-specific migration of lymphocytes.

Authors:  Eric J Kunkel; Eugene C Butcher
Journal:  Immunity       Date:  2002-01       Impact factor: 31.745

2.  Targeting of nasal mucosa-associated antigen-presenting cells in vivo with an outer membrane protein A derived from Klebsiella pneumoniae.

Authors:  L Goetsch; A Gonzalez; H Plotnicky-Gilquin; J F Haeuw; J P Aubry; A Beck; J Y Bonnefoy; N Corvaïa
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

3.  Effective mucosal immunization against respiratory syncytial virus using purified F protein and a genetically detoxified cholera holotoxin, CT-E29H.

Authors:  P W Tebbey; C A Scheuer; J A Peek; D Zhu; N A LaPierre; B A Green; E D Phillips; A R Ibraghimov; J H Eldridge; G E Hancock
Journal:  Vaccine       Date:  2000-06-01       Impact factor: 3.641

4.  Characteristics of immunity induced by viral antigen or conferred by antibody via different administration routes.

Authors:  T Matsuoka; Y Okamoto; Z Matsuzaki; S Endo; E Ito; H Tsutsumi; R A Williamson; H Sakurai; D R Burton; I Saito
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

5.  Nasal-associated lymphoid tissue: phenotypic and functional evidence for the primary role of peripheral node addressin in naive lymphocyte adhesion to high endothelial venules in a mucosal site.

Authors:  K L Csencsits; M A Jutila; D W Pascual
Journal:  J Immunol       Date:  1999-08-01       Impact factor: 5.422

6.  IL-12-activated NK cells reduce lung eosinophilia to the attachment protein of respiratory syncytial virus but do not enhance the severity of illness in CD8 T cell-immunodeficient conditions.

Authors:  T Hussell; P J Openshaw
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

Review 7.  Immunity, inflammation, and remodeling in the airway epithelial barrier: epithelial-viral-allergic paradigm.

Authors:  Michael J Holtzman; Jeffrey D Morton; Laurie P Shornick; Jeffrey W Tyner; Mary P O'Sullivan; Aurita Antao; Mindy Lo; Mario Castro; Michael J Walter
Journal:  Physiol Rev       Date:  2002-01       Impact factor: 37.312

Review 8.  No one is naive: the significance of heterologous T-cell immunity.

Authors:  Raymond M Welsh; Liisa K Selin
Journal:  Nat Rev Immunol       Date:  2002-06       Impact factor: 53.106

9.  Vaccination with recombinant alphavirus or immune-stimulating complex antigen against respiratory syncytial virus.

Authors:  Margaret Chen; Ke-Fei Hu; Björn Rozell; Claes Orvell; Bror Morein; Peter Liljeström
Journal:  J Immunol       Date:  2002-09-15       Impact factor: 5.422

10.  Influenza virus lung infection protects from respiratory syncytial virus-induced immunopathology.

Authors:  G Walzl; S Tafuro; P Moss; P J Openshaw; T Hussell
Journal:  J Exp Med       Date:  2000-11-06       Impact factor: 14.307
View more
  5 in total

1.  An investigation of the ability of orally primed and tolerised T cells to help B cells upon mucosal challenge.

Authors:  Natalie Kobets; Kim Kennedy; Deborah O'Donnell; Paul Garside
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

Review 2.  Lactococcus lactis as an adjuvant and delivery vehicle of antigens against pneumococcal respiratory infections.

Authors:  Marcela Medina; Elisa Vintiñi; Julio Villena; Raul Raya; Susana Alvarez
Journal:  Bioeng Bugs       Date:  2010 Sep-Oct

3.  Nasal-associated lymphoid tissue (NALT): frequency and localization in young children.

Authors:  A S Debertin; T Tschernig; H Tönjes; W J Kleemann; H D Tröger; R Pabst
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

4.  Host immunity in the protective response to nasal immunization with a pneumococcal antigen associated to live and heat-killed Lactobacillus casei.

Authors:  Elisa O Vintiñi; Marcela S Medina
Journal:  BMC Immunol       Date:  2011-08-11       Impact factor: 3.615

5.  Evaluation of an intranasal virosomal vaccine against respiratory syncytial virus in mice: effect of TLR2 and NOD2 ligands on induction of systemic and mucosal immune responses.

Authors:  Muhammad Shafique; Tjarko Meijerhof; Jan Wilschut; Aalzen de Haan
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.